Improved glycemic control and reduced nocturnal hypoglycemia in patients with type 2 diabetes with morning administration of insulin glargine compared with NPH insulin

被引：0

|

作者：

Fritsche, A

Schweitzer, MA

Haring, H

机构：

来源：

DIABETES | 2002年 / 51卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

220

引用

收藏

页码：A54 / A54

页数：1

相关论文

共 50 条

[1] Improved glycaemic control and reduced nocturnal hypoglycaemia in patients with Type 2 diabetes with morning administration of insulin glargine compared with NPH insulin
Fritsche, A
Schweitzer, MA
Häring, H
[J]. DIABETOLOGIA, 2002, 45 : A52 - A52
[2] Reduced hypoglycemia risk with insulin glargine - A metaanalysis comparing insulin glargine with human NPH insulin in type 2 diabetes
Rosenstock, J
Dailey, G
Massi-Benedetti, M
Fritsche, A
Lin, ZN
Salzman, A
[J]. DIABETES CARE, 2005, 28 (04) : 950 - 955
[3] Economic impact of nocturnal hypoglycemia associated with the treatment of type 2 diabetes with insulin glargine or NPH insulin
Rubio-Terres, Carlos
Alvarez Guisasola, Fernando
Navarro Perez, Jorge
Delgado Alvarez, Elias
Azriel Mira, Sharona
Magana, Ana
[J]. AVANCES EN DIABETOLOGIA, 2013, 29 (01): : 19 - 26
[4] Less symptomatic hypoglycemia with insulin glargine compared to NPH in patients with type 2 diabetes.
Fonseca, V
Bell, D
Mecca, T
[J]. DIABETOLOGIA, 2001, 44 : A207 - A207
[5] Better Glycemic Control with Lesser Hypoglycemia on Transition Insulin Glargine Administration at Bedtime to Morning in Type 2 Diabetes Mellitus
Kabadi, Udaya M.
[J]. DIABETES, 2015, 64 : A641 - A641
[6] Less symptomatic hypoglycemia with bedtime insulin glargine (Lantus®) compared to bedtime NPH insulin in patients with type 2 diabetes
Fonseca, V
Bell, D
Mecca, T
[J]. DIABETES, 2001, 50 : A112 - A112
[7] Glycemic control and hypoglycemia in Asian type 2 diabetes patients treated with insulin glargine plus glimepiride versus NPH insulin plus glimepiride
Pan, CY
Bianchi-Biscay, M
Chung, KD
Kim, KW
[J]. DIABETES, 2004, 53 : A488 - A488
[8] Insulin detemir improves glycemic control with reduced risk of hypoglycemia and weight loss in patients previously treated with insulin glargine or NPH insulin
Meneghini, Luigi
Koenen, Christoph
Rojas, Patrick
Selam, Jean-Louis
[J]. DIABETES, 2007, 56 : A573 - A573
[9] Co-administration of insulin glargine with oral therapy in patients with Type 2 diabetes allows flexible dosing and improved glycaemic control with reduced hypoglycaemia compared with NPH insulin.
Busch, K
Fritsche, A
Häring, HU
Schweitzer, MA
Vesper, I
[J]. DIABETOLOGIA, 2003, 46 : A6 - A6
[10] Pharmacoeconomic analysis of insulin glargine compared with NPH insulin in patients with type 2 diabetes in Spain
Terres, CR
Rodríguez, J
Bolinder, B
De Pablos, P
[J]. DIABETES, 2004, 53 : A291 - A291

← 1 2 3 4 5 →